PSA and SHPA sign MoU

A Memorandum of Understanding (MoU) has been signed by the Pharmaceutical Society of Australia (PSA) and the Society of Hospital Pharmacists (SHPA) enabling closer commitment and cooperation between the two organisations.

PSA National President, Dr Chris Freeman, says the goal of the MoU is to unite the pharmacy profession for the betterment of patient outcomes, “and to lift the profile and engagement of pharmacists within the healthcare team.”

“In the same vein, this MoU is about embracing strategic commonalities and finding new ways of working closer with SHPA to deliver a wider range of events, services and supports for members, while uniting the pharmacy profession toward our common goals,” continued Dr Freeman.

“It is an exciting time for PSA as we prepare to take a seat at the table for negotiations regarding the Seventh Community Pharmacy Agreement (7CPA),” he added.

Reportedly, this close commitment and cooperation aligns with both the PSA’s and SHPA’s respective five-year plans, which includes:

  • Achieving excellence in pharmacy care benefiting all Australians.
  • Supporting pharmacist members to thrive and succeed.
  • Amplifying members’ voices to effect real and positive change.

“Three areas of alignment clearly stand out,” SHPA President Peter Fowler said. “These will be the backbone of this MoU – identifying and developing new approaches … to improve the practice, impact and membership experience of all PSA and SHPA members.”

The announcement came on the second day of the 2019 PSA National Conference in Sydney.

Check Also

Calling innovators as MS prize is launched

In partnership with WIRED Brand Lab and other collaborators, such as Shift.ms and Techstars, Novartis …